Genus Oncology, LLC (Genus)

Oncology Corporate Profile

HQ Location

3 Hawthorn Parkway, Suite 250
Vernon Hills, IL 60061

Company Description

Genus Oncology, LLC, is a clinical-stage company formed in 2007 with a mission of discovering, developing, and commercializing new anti-cancer agents that target the Mucin 1 (MUC1) oncoprotein. Genus' intellectual capital includes over 20 years of research at Dana-Farber Cancer Institute (DFCI), Harvard Medical School, and a senior management team with significant pharmaceutical industry experience in leading successful discovery, development, and commercialization initiatives.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
GO-203-2cMUC1 inhibitorAcute Myelogenous Leukemia (AML)I
GO-203-2cMUC1 inhibitorMultiple MyelomaI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display